HYTN Innovations Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-29
Interim MD&A - English.pdf
Results 2026-05-29
Interim financial statements/report – English.pdf
News 2026-05-07
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
News release - English.pdf
News 2026-04-30
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
News release - English.pdf
Transactions 2026-04-24 M&A
HYTN Innovations Inc. Announces Material Change Regarding Spin-Out of Peptide Drug Development Business
Material change report - English.pdf
Transactions 2026-04-23 M&A
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
News release - English.pdf
News 2026-04-17
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
News release - English.pdf
News 2026-03-27
HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
News release - English.pdf
News 2026-03-09
Report of exempt distribution (45-106F1).pdf
Results 2026-03-02 Financials
Interim MD&A - English.pdf
Results 2026-03-02 Financials
Interim financial statements/report – English.pdf
Results 2026-01-29 Financials
Annual MD&A - English.pdf
Results 2026-01-29 Financials
Audited annual financial statements – English.pdf
News 2026-01-09
HYTN Announces Engagement of Marketing and Communications Services Provider
News release - English.pdf
News 2025-12-18
HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
News release - English.pdf
Results 2025-08-28 Financials
Interim MD&A - English.pdf
Results 2025-08-28 Financials
Interim financial statements/report – English.pdf
News 2025-07-14
News release - English.pdf
News 2025-07-04
Other.pdf
News 2025-07-04
Other.pdf
News 2025-07-04
Other.pdf
News 2025-06-11
News release - English.pdf